Breaking News
CRISPR QC Co-founder Kiana Aran Makes Inc.’s 2023 Female Founders List
CRISPR QC is proud to announce that co-founder Kiana Aran has been recognized by Inc. magazine as a top 200 Female Founder. This prestigious list highlights women entrepreneurs who are making a significant impact in their respective industries and driving change.
Dr. Kiana Aran is a world-renowned bioengineer and innovator; she co-founded CRISPR QC with the mission to provide cutting-edge tools and technologies for CRISPR research and development. Dr. Aran is the inventor of the CRISPR-Chip, a groundbreaking technology that enables real-time, direct measurements of CRISPR activity that can advance sustainable agriculture and gene therapy development.
“As a female founder, I hope to inspire other women to have the courage and intellectual bravery to pursue their entrepreneurial goals,” says Dr. Aran. “The development of CRISPR-Chip technology has proven to be incredibly valuable for the CRISPR industry, and I am thrilled to see the impact of my work. This recognition from Inc. magazine is incredibly rewarding and motivates me to continue pushing boundaries in biotechnology innovations. I am excited to further bridge the gap between the benches in my academic lab and effective commercial applications.”
CRISPR QC congratulates Kiana Aran on this well-deserved recognition on Inc.’s 2023 Female Founders List and looks forward to her continued leadership.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more